GlassScriptPhysician profile
Ellen M Burkett
NPI 1659334118
$536.94
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $233 · 2022: $24.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $114.72 | 2019-2020 | |
| Amgen INC. | $79.84 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $44.86 | 2019-2020 | |
| Abbott Laboratories | $40.69 | 2020 | |
| Glaxosmithkline, LLC. | $35.64 | 2019-2020 | |
| Medtronic, INC. | $24.93 | 2022 | |
| Eisai INC. | $24.47 | 2020 | |
| Genentech USA, INC. | $22.53 | 2020 | |
| Astellas Pharma US INC | $19.31 | 2019 | |
| Shire North American Group INC | $19.06 | 2019 | |
| Amarin Pharma, INC. | $17.62 | 2019 | |
| Therapeuticsmd, INC. | $17.09 | 2019 | |
| Boston Scientific Corporation | $17.04 | 2019 | |
| Horizon Therapeutics Plc | $16.62 | 2019 | |
| Pfizer INC. | $15.50 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.01 | 2020 | |
| Ethicon US, LLC | $13.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Burkett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.